Falsified Medicines Directive (FMD)
Following adoption by the Council and the European Parliament, the Falsified Medicines Directive (Directive 2011/62/EU) was published on 1 July 2011 in the Official Journal of the European Union. The Falsified Medicines Directive had to be transposed by member states by 2 January 2013.
The Directive introduces tougher rules to ensure medicines are safe and that the trade in medicines is rigorously controlled. This is a reaction to a reported significant increase of false medicinal products detected within the legal supply chain of the Member States. Counterfeiting high-price medicines is perceived as a growing illegal business and a threat to public health worldwide.
For further information on what is proposed and the implications for practices please click HERE .